Genetic Variants in the Folate Pathway and the Risk of Neural Tube Defects: A Meta-Analysis of the Published Literature

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Zhang, Ti ^a   Lou, Jiao ^a   Zhong, Rong ^a   Wu, Jing ^a   Zou, Li ^a   Sun, Yu ^a   Lu, Xuzai ^a   Liu, Li ^b   Miao, Xiaoping ^a   Xiong, Guanglian ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENOSINE; CYTIDINE; FOLIC ACID; GUANIDINE; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; REDUCED FOLATE CARRIER; THYMIDINE;

ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MTHFR GENE; MTR GENE; MTRR GENE; NEURAL TUBE DEFECT; POPULATION BASED CASE CONTROL STUDY; RFC 1 GENE; RISK ASSESSMENT; SYSTEMATIC REVIEW;

ALLELES; CASE-CONTROL STUDIES; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; GENE FREQUENCY; HUMANS; METABOLIC NETWORKS AND PATHWAYS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEURAL TUBE DEFECTS; ODDS RATIO; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMORPHISM, GENETIC; PUBLICATION BIAS; REPLICATION PROTEIN C;

EID: 84875963812     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059570     Document Type: Article

References (48)

1. Christianson A (2006) Global Report on Birth Defects. March of Dimes Birth Defects Foundation.
2. Pitkin RM, (2007) Folate and neural tube defects. Am J Clin Nutr 85: 285S-288S.
3. Copp AJ, Greene ND, Murdoch JN, (2003) The genetic basis of mammalian neurulation. Nat Rev Genet 4: 784-793.
4. Detrait ER, George TM, Etchevers HC, Gilbert JR, Vekemans M, et al. (2005) Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol 27: 515-524.
5. Smithells RW, Sheppard S, Schorah CJ, (1976) Vitamin dificiencies and neural tube defects. Arch Dis Child 51: 944-950.
6. Wolff T, Witkop CT, Miller T, Syed SB, (2009) Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 150: 632-639.
7. Laurence KM, (1985) Prevention of neural tube defects by improvement in maternal diet and preconceptional folic acid supplementation. Prog Clin Biol Res 163B: 383-388.
8. Christiansen M, Garne E, (2005) [Prevention of neural tube defects with periconceptional folic acid supplementation in Europe]. Ugeskr Laeger 167: 2875-2876.
9. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, et al. (1999) Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341: 1485-1490.
10. Kibar Z, Capra V, Gros P, (2007) Toward understanding the genetic basis of neural tube defects. Clin Genet 71: 295-310.
11. De-Regil LM, Fernandez-Gaxiola AC, Dowswell T, Pena-Rosas JP (2010) Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev: CD007950.
12. Rothenberg SP, da Costa MP, Sequeira JM, Cracco J, Roberts JL, et al. (2004) Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med 350: 134-142.
13. Yates JR, Ferguson-Smith MA, Shenkin A, Guzman-Rodriguez R, White M, et al. (1987) Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects? Clin Genet 31: 279-287.
14. van der Put NM, Thomas CM, Eskes TK, Trijbels FJ, Steegers-Theunissen RP, et al. (1997) Altered folate and vitamin B12 metabolism in families with spina bifida offspring. QJM 90: 505-510.
15. Bassuk AG, Kibar Z, (2009) Genetic basis of neural tube defects. Semin Pediatr Neurol 16: 101-110.
16. Ulrich CM, Robien K, McLeod HL, (2003) Cancer pharmacogenetics: Polymorphisms, pathways and beyond. Nature Reviews Cancer 3: 912-920.
17. Molloy AM, Brody LC, Mills JL, Scott JM, Kirke PN, (2009) The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects. Birth Defects Res A Clin Mol Teratol 85: 285-294.
18. Richter B, Stegmann K, Roper B, Boddeker I, Ngo ET, et al. (2001) Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population. J Hum Genet 46: 105-109.
19. Collin SM, Metcalfe C, Zuccolo L, Lewis SJ, Chen L, et al. (2009) Association of Folate-Pathway Gene Polymorphisms with the Risk of Prostate Cancer: a Population-Based Nested Case-Control Study, Systematic Review, and Meta-analysis. Cancer Epidemiology Biomarkers & Prevention 18: 2528-2539.
20. van der Linden IJM, Afman LA, Heil SG, Blom HJ, (2007) Genetic variation in genes of folate metabolism and neural-tube defect risk. Proceedings of the Nutrition Society 65: 204-215.
21. Beaudin AE, Stover PJ, (2007) Folate-mediated one-carbon metabolism and neural tube defects: balancing genome synthesis and gene expression. Birth Defects Res C Embryo Today 81: 183-203.
22. Bjorke-Monsen AL, Ueland PM, Schneede J, Vollset SE, Refsum H, (1997) Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida. QJM 90: 593-596.
23. Copp AJ, Greene ND, (2010) Genetics and development of neural tube defects. J Pathol 220: 217-230.
24. Boduroǧlu K, (2005) Analysis of MTHFR 1298A>C in addition to MTHFR 677C>T polymorphism as a risk factor for neural tube defects in the Turkish population. The Turkish Journal of Pediatrics 47: 327-333.
25. Kirke PN, (2004) Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. British Medical Journal 328: 1535-1536.
26. Marco PD, (2002) Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 47: 319-324.
27. Parle-McDermott A, Mills JL, Kirke PN, O'Leary VB, Swanson DA, et al. (2003) Analysis of the MTHFR 1298A>C and 677C>T polymorphisms as risk factors for neural tube defects. Journal of Human Genetics 48: 190-193.
28. Shaw GM, Rozen R, Finnell RH, Wasserman CR, Lammer EJ, (1998) Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am J Epidemiol 148: 30-37.
29. Relton CL, (2004) Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. Journal of Medical Genetics 41: 256-260.
30. Godbole K, Gayathri P, Ghule S, Sasirekha BV, Kanitkar-Damle A, et al. (2011) Maternal one-carbon metabolism, MTHFR and TCN2 genotypes and neural tube defects in India. Birth Defects Res A Clin Mol Teratol 91: 848-856.
31. Franchis RD, (1998) The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy. J Med Genet 35: 1009-1013.
32. Mornet E, Muller F, Lenvoise-Furet A, Delezoide AL, Col JY, et al. (1997) Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet 100: 512-514.
33. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62: 1006-1012.
34. Zintzaras E, Doxani C, Koufakis T, Kastanis A, Rodopoulou P, et al. (2011) Synopsis and meta-analysis of genetic association studies in osteoporosis for the focal adhesion family genes: the CUMAGAS-OSTEOporosis information system. BMC Medicine 9: 9.
35. Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, et al. (2005) Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 162: 201-211.
36. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
37. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J, (2005) A method for meta-analysis of molecular association studies. Stat Med 24: 1291-1306.
38. Thompson SG, Higgins JP, (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21: 1559-1573.
39. Motulsky AG, (1996) Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 58: 17-20.
40. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, et al. (2002) A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A 99: 5606-5611.
41. Kondo A, Kamihira O, Ozawa H, (2009) Neural tube defects: prevalence, etiology and prevention. Int J Urol 16: 49-57.
42. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113.
43. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R, (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64: 169-172.
44. van der Put NM, Eskes TK, Blom HJ, (1997) Is the common 677C->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. QJM 90: 111-115.
45. Amorim MR, Lima MAC, Castilla EE, Orioli IM, (2007) Non-Latin European descent could be a requirement for association of NTDs andMTHFR variant 677C > T: A meta-analysis. American Journal of Medical Genetics Part A 143A: 1726-1732.
46. Ou CY, (1996) 5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for Neural Tube Deffects. American Journal of Medical Genetics 63: 610-614.
47. Li YN, Gulati S, Baker PJ, Brody LC, Banerjee R, et al. (1996) Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet 5: 1851-1858.
48. Selzer RR, Rosenblatt DS, Laxova R, Hogan K, (2003) Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency. N Engl J Med 349: 45-50.